These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9885364)

  • 1. Profiles of plasma serpins in patients with advanced malignant melanoma, gastric cancer and breast cancer.
    Wojtukiewicz MZ; Ruciñska M; Kloczko J; Dib A; Galar M
    Haemostasis; 1998; 28(1):7-13. PubMed ID: 9885364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human pancreatic proteinases by human plasma alpha2-antiplasmin and antithrombin.
    Nobar SM; Guy-Crotte O; Rabaud M; Bieth JG
    Biol Chem; 2004 May; 385(5):423-7. PubMed ID: 15196003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional role of acute phase plasma proteinase inhibitors.
    Travis J; Shieh BH; Potempa J
    Tokai J Exp Clin Med; 1988 Dec; 13(6):313-20. PubMed ID: 3152555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
    Luo LY; Jiang W
    Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpins identified as cell growth inhibitors in human plasma.
    Yao J; Baecher-Allan CM; Sharon J
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):76-81. PubMed ID: 10775503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.
    Mauron T; Lämmle B; Wuillemin WA
    Thromb Haemost; 1998 Jul; 80(1):82-6. PubMed ID: 9684790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.
    Weiss A; Joerss H; Brockmeyer J
    PLoS One; 2014; 9(10):e111363. PubMed ID: 25347319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and gastric fibrinolysis in patients with gastric carcinoma.
    Prokopowicz J; Gabryelewicz A; Wołosowicz N; Szałaj W; Puchalski Z
    Z Exp Chir; 1975; 8(5):309-12. PubMed ID: 1053190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin.
    Murakami Y; Wada Y; Kobayashi H; Irie A; Hasegawa M; Yamanaka H; Okamoto K; Eto M; Imamura T
    Biol Chem; 2012 Oct; 393(10):1193-200. PubMed ID: 23089609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematological disorders in patients with gastric cancer].
    Yamamura T
    Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):675-85. PubMed ID: 6493191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic significance of coagulation assays in melanoma.
    Tas F; Ciftci R; Kilic L; Bilgin E; Keskin S; Sen F; Yildiz I; Yasasever V
    Melanoma Res; 2012 Oct; 22(5):368-75. PubMed ID: 22889867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
    Brown MA; Scuderi P; McIntosh JC; Pfeffer K; Parsons P
    Am Rev Respir Dis; 1990 Oct; 142(4):984-5. PubMed ID: 2221602
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
    McCulloch P; Douglas J; Lowe GD; Murray G; George WD
    Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
    Hofmann G; Balic M; Dandachi N; Resel M; Schippinger W; Regitnig P; Samonigg H; Bauernhofer T
    Clin Biochem; 2013 Oct; 46(15):1585-9. PubMed ID: 23792261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in fibrinolysis in patients with localized tumors.
    Mannucci PM; Cugno M; Bottasso B; Marongiu F; Maniezzo M; Vaglini M; Cascinelli N
    Eur J Cancer; 1990 Feb; 26(2):83-7. PubMed ID: 2138910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
    Kamel AM; Teama S; Fawzy A; El Deftar M
    Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.